Risk.net

Firms Drag Heels on MiFID II Research Rulebook Rewrite

MiFID II’s ban on broker-subsidized free research will leave sell-side firms with a multitude of challenges—not least how to price research so as not to lose customers who might direct trading elsewhere, without appearing to incentivize clients to trade. Kirsten Hyde examines the pricing challenges facing buy- and sell-side firms, and the potential fallout from the new unbundling rules.

August 2017: Another Example of Our Industry Growing Up

The unbundling of research will present new challenges for the industry, but on balance, it should be good.

Editor's choice